NCT00302653 2009-09-25
Rasburicase in Tumor Lysis Syndrome
Sanofi
Phase 4 Completed
Clinical Trials
4 trialsNCT00230217 2009-03-30
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
Sanofi
Phase 4 Completed
NCT00651911 2008-04-03
Fasturtec TLS Treatment / Prophylysis
Sanofi
Phase 4 Completed
NCT00563771 2008-01-28
Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome
Sanofi
Phase 4 Completed